Abstract
The protection of cells expressing class I HLA molecules from NK lysis is mediated by natural killer cell inhibitory receptors (NKIR). Using site-directed mutagenesis, residues on HLA-C that determine the locus specificity (αVal-76), allotype group specificity (a dimorphism αAsn-80/Lys-80), and affinity of NKIR binding (a second pair of dimorphisms, αAla-73, Asp-90 or αThr-73, Ala-90) have been identified. Thus the 'footprint' of the NKIR on the α1 helix of the class I MHC molecule HLA-C and its associated β strands are similar in position to the site occupied by superantigens on and behind the α1 helix of the class II MHC molecule HLA-DR1, but further toward its C-terminus. The intermediate affinity binding of NKIR to HLA-C, determined by α73 and α90, has an essential role in preventing cross-reactivity and ensuring the availability of NK cells for immunosurveillance; low affinity and high affinity mutants are both physiologically impaired.
| Original language | English |
|---|---|
| Pages (from-to) | 341-350 |
| Number of pages | 10 |
| Journal | Immunity |
| Volume | 6 |
| Issue number | 3 |
| DOIs | |
| State | Published - Mar 1997 |
| Externally published | Yes |
Bibliographical note
Funding Information:This work was supported by National Institutes of Health grant CA-47554. O. M. is an EMBO Fellow and a Fulbright scholar. H. T. R. holds a Wellcome Trust International Prize Travelling Research Fellowship. L. P. is a recipient of an Arthritis Foundation postdoctoral fellowship.